Abstract

Dr Douglas Clarkson looks at how developments in medical screening techniques are showing promise in the identification and monitoring of central nervous system degenerative diseases such as Alzheimer's disease.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call